study of an ayurvedic preparation pippalyadi vati in the management of disease Vataj pratishyay which is correlated with disease acute rhinitis in modern science

Open Randomized Control Clinical Trial of Pippalyadi vati in Vataja Pratishyaya with special reference to Acute Rhinitis (COMMON COLD) - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084295

Enrollment

Registered

2025-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from theVatajaPratishyaya (Acute Rhinitis-common cold). 2. Patients of Age Group 18 To 60 years, irrespective of their gender, religion, occupation. 3. All patients having signs and symptoms - 1.Aanaddhapihita (Nasal Obstruction) 2.Tanustrava (Rhinorrhoea) 3. Kshavathu (Sneezing) 4. jwara (fever)

Exclusion criteria

Exclusion criteria: 1. Pregnant women and children 2. History of congenital disorder of nose 3. Known cases of chronic specific infective rhinitis, syphilis, leprosy, tuberculosis, Lupus vulgaris, fungal infections, 4. Patients with nasal polyp, neoplasm

Design outcomes

Primary

Measure	Time frame
Pippalyadi Vati is More Effective Than Fexofenadine in Acute Rhinitis (Common Cold )Timepoint: 1 BD for 7 days	—

Secondary

Measure	Time frame
Pippalyadi vati is equally effective as Fexofenadine in Acute Rhinitis (Common Cold).Timepoint: 1 BD for 7 days	—

Countries

India

Contacts

Public ContactDr Jayvant Kharat

Hon. Shri Annasaheb Dange Ayurved Medical College and Post Graduate Research Centre Ashta Tq Walwa

jayvantkharat55@gmail.com9604010037

Outcome results